I believe the company was capable and well run when it previously operated in a unique niche segment of the market under a very conservative management.
Management has changed and has made a meaningful acquisition. I would feel more comfortable if new management proved that they can continue to run the company well, that the new acquisition has been bedded down well and is delivering the expected benefits and that they can grow the business organically, before they go on an acquisition spree.
I am more than happy to give up a special dividend or two to build up cash reserves and fund future acquisitions, but I am just not sure that people who invested in SND for stable cashflows necessarily want to see the company change into an acquisition driven growth-business.
As for myself, I would have been happy to see an acquisition or two that counter some of the historic cyclicality suffered by SND, but see it maintain its strong focus on cashflow generation and dividend payments.
Also, if the CR is to the exclusive benefit of institutional investors, I am happy to start looking for value elsewhere...
- Forums
- ASX - By Stock
- SND
- Ann: Trading Halt
Ann: Trading Halt, page-5
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SND (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5332 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.5¢ | 11841 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.340 |
1 | 3750 | 0.310 |
1 | 6543 | 0.300 |
2 | 39000 | 0.290 |
1 | 30000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 80659 | 1 |
0.360 | 48280 | 1 |
0.400 | 15021 | 1 |
0.410 | 40000 | 1 |
0.440 | 25000 | 1 |
Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
Featured News
SND (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online